CA
NZ
UK
AU
IND
US
ANI Pharmaceuticals, Inc. filed a Form 8-K on August 24, 2026, reporting the appointment of Henry Gosebruch to its Board of Directors and the resignation of Muthusamy "Samy" Shanmugam from the Board, both effective August 2026.
Philip Morris International Inc. filed a current report on August 24, 2026, disclosing that it has entered, through certain of its non-U.S. affiliates, into a contract manufacturing arrangement for combustible cigarettes with Philip Morris USA, an operating company of Altria Group Inc.
Martin Marietta Materials, Inc. filed a Form 8-K on August 24, 2026, reporting the August 21, 2026 closing of its acquisition of Lhoist North America, Inc. from LNA Holding SRL for approximately $7 billion in cash and 10,953,543 newly issued shares of Martin Marietta …
RUM Group Inc. filed a Form 8-K on August 24, 2026, disclosing that on August 23, 2026, the company entered into a binding warrant term sheet with an unaffiliated U.S.-based third party cloud customer in connection with a commercial agreement for GPU services at …
Strive, Inc. filed a Form 8-K with the SEC on August 24, 2026, disclosing the purchase of 1,110 bitcoin between August 17 and August 21, 2026, and providing updated holdings and share data as of August 21, 2026.
Strategy Inc filed an 8-K with the SEC on August 24, 2026, disclosing the establishment of a new "USD Cash" liquidity component within its Digital Credit Capital Framework, along with weekly updates on its ATM offering, bitcoin holdings, and share repurchase activity.
Kimbell Royalty Partners, LP filed a Form 8-K with the SEC on August 24, 2026, reporting the completion on August 21, 2026 of a previously announced acquisition of mineral and royalty interests from Rivercrest Capital Partners LP, Rivercrest Capital Partners II LP, and Cupola …
Azenta, Inc. (NASDAQ:AZTA) filed a Form 8-K on August 24, 2026, reporting that President and Chief Executive Officer John P. Marotta resigned effective August 22, 2026, and that the Board elected Dr. Martin D. Madaus as Interim President and Chief Executive Officer on the …
Erasca, Inc. filed a current report on Form 8-K on August 24, 2026, disclosing that the U.S. Food and Drug Administration granted Fast Track Designation to ERAS-0015 for the treatment of patients with metastatic pancreatic adenocarcinoma.
QCR Holdings, Inc. filed a Form 8-K with the SEC on August 24, 2026, disclosing a cash dividend declaration of $0.15 per share of common stock, payable on October 5, 2026 to stockholders of record as of September 18, 2026.
Please wait processing your request...